Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Cellophil™ is a platform of novel polymers based on amino-acid groups. The platform polymers show superior biocompatibility and can be loaded with drugs for controlled release. More
PsoriaVaTM incorporates calcipotriene 0.005%/betamethasone 0.64%) and the NexACT® technology. Pre-clinical studies have shown PsoriaVA® to deliver the same level of drugs as Taclonex with indication of superior safety profile. More
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms More
OTC Chitosan Gel (ANX-011): A Nasal Gel Formulation for Cold and Flu Treatment that is Commercially Ready More
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
Betamethasone Valerate 0.12% Emollient Foam: Alcohol-free, Easy to Use and Stable Betamethasone Foam More
Direct Selection of Hybridomas (DiSH) for the Production of Monoclonal Antibodies More
Increasing the stability and improving the reconstitution of biomolecules using supercritical fluid (SCF) processing More
Bilosomes: A Novel Technology for Oral Vaccine Delivery More
Food allergies to fish or cephalopods can be triggered by antigens remaining after treatments to prevent parasitic diseases caused by Anisakis. We have developed an extraction and immunology method to detect these allergens in frozen and cooked food More
Related Reports
Market Research Reports provided by reports.innovaro.com
Nov 2010 - 40 pages - $500
Nov 2010 - 1517 pages - $1,495
May 2011 - 34 pages - $500
Dec 2010 - 48 pages - $500
May 2011 - 39 pages - $500
Enjoy Life Natural Brands Case Study: capitalizing on rising consumer interest in anti-allergy foods
Aug 2009 - 11 pages - $295
Jul 2010 - 180 pages - $750
May 2011 - 35 pages - $125
Feb 2011 - 28 pages - $125
Nov 2010 - 37 pages - $600
Your selection
- Therapeutic target
- Allergy del
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Therapeutic target
- Allergic rhinitis (hay fever)
- Allergies (other)
- Allergy, ophthalmic
- Allergy, skin
- Anaphylaxis
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us